Company Filing History:
1 out of 3 
1 out of 12 Years Active: 2021
Title: The Innovative Contributions of Magdalena Bakun
Introduction
Magdalena Bakun is a prominent inventor based in Warsaw, Poland. She has made significant strides in the field of medical diagnostics, particularly in relation to IgA nephropathy. Her work has the potential to improve the diagnosis and monitoring of this kidney disease, showcasing her dedication to advancing healthcare through innovation.
Latest Patents
Magdalena Bakun holds a patent for a method titled "Methods for diagnosis, differentiation and monitoring using urine proteins as markers in IgA nephropathy." This innovative method utilizes a combination of alpha-1B-glycoprotein (A1BG), orosomucoid 1 (ORMI), and Ig lambda-2 chain C regions (IGLC2) as protein markers found in urine samples. This approach aims to enhance the accuracy of diagnosing IgA nephropathy, which is crucial for effective patient management.
Career Highlights
Throughout her career, Magdalena has worked with esteemed institutions such as the Institute of Biochemistry and Biophysics of the Polish Academy of Sciences and the Medical University of Warsaw. Her contributions to these organizations have been instrumental in advancing research and development in the field of biochemistry and medical diagnostics.
Collaborations
Magdalena has collaborated with notable colleagues, including Krzysztof Mucha and Leszek Paczek. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, further enhancing the impact of her work.
Conclusion
Magdalena Bakun's contributions to medical diagnostics, particularly in the area of IgA nephropathy, highlight her role as an influential inventor. Her patent and collaborations reflect her commitment to improving healthcare outcomes through innovative solutions.